As confirmed by the company on Friday, the US Food and Drug Administration has awarded approval to a new "neurostimulation device" by St. Jude Medical Inc., the developer and manufacturer of medical devices and equipment, aimed at effectively treating aches in patients of chronic pain.

The device is actuallya "MultiSteering Technology software" for the medical company's "Rapid ProgrammerT". The device has been christened Penta, and is essentially a surgical wire fitted with multiple electrodes, which deliver electrical pulses in spaces near a patient's spine.

"This latest software advancement provides clinicians with a tool that allows them to customize each patient's therapy faster and more efficiently than conventional programming. The introduction of MultiSteering Technology also expands our programming capabilities to help improve patient outcomes for even the most challenging of cases", said Chris Chavez, President of the St. Jude Medical Neuromodulation Division.

"Neurostimulation Therapy" is essentially used for management of chronic pain of the trunk and limbs, in addition to pain from back surgeries that have not been successful. The American Pain Foundation has estimated that about 76.5 million people in the Us are currently categorized as suffering from chronic pain, and the new offering can be a boon for them.